IgniteData leaders Steve Tolle and Jose Galvez share how IgniteData Archer has grown from its oncology trial beginnings to supporting multiple therapeutic areas worldwide.
They highlight the importance of structured data standards, evolving site workflows, and how new capabilities—like adverse event reporting and medical history—are shaping the future of clinical trials.